Stereotactic body radiotherapy was associated with significantly better urinary continence and fewer sexual issues at 2 years ...

Men with localized prostate cancer were randomly assigned to receive either SBRT or control radiotherapy in a phase 3 trial.

In metastatic hormone-sensitive prostate cancer (mHSPC), adding the radioligand 177 Lu-PSMA-617 (Pluvicto) to androgen ...

Men with prostate cancer diagnosed at an early stage may be able to slow the progression of their disease by adopting a ...

In a study believed to be the first of its kind published, a research team led by Johns Hopkins Medicine provides scientific ...

Increase of 11,000 cases means more men face risk of deadlier late-stage disease ...

Exclusive: “Unfortunately, most of the genetic research that had been published focused only on people of white, European ...

Prostate cancer is the second leading cause of cancer death among American men. A recent study, conducted by researchers from ...

Prostate cancer poses a significant threat to South African men, especially black men who are at a higher risk. This article ...

The legacy of Steve Abbott helped a local organization save lives by raising awareness about early detection of the disease.

More than 52,000 people are diagnosed with prostate cancer every year, making it the most common cancer that affects men.

Stereotactic body radiotherapy (SBRT) is noninferior to conventional or moderately fractionated radiotherapy for loc ...